BioMarin Pharmaceutical Inc.

(BMRN) Trade

By |

Profile

BioMarin's focus is on rare-disease therapies. Genzyme (now part of Sanofi) markets Aldurazyme through its joint venture with BioMarin, and BioMarin markets Naglazyme, Vimizim, and Brineura independently. BioMarin also markets Kuvan and Palynziq to treat the rare metabolic disorder PKU (in addition to long-standing U.S. rights, BioMarin has reacquired international rights for Kuvan and Palynziq from Merck KGaA). BioMarin has a hemophilia A gene therapy and a treatment for achondroplasia in late-stage clinical trials.

Contact Information

Website: www.bmrn.com
Email: IR@BMRN.com
Main Phone: +1 415 506-6700
Address: 770 Lindaro Street
State: CA
City / Town: San Rafael
Country: USA
Postal Code: 94901

Issuer Information

Exchange: NGS
CEO: Jean-Jacques Bienaime
Employees: 2581
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 93.83 $ 0. (0.00%)
Last Price 93.83 Change $ 0. Change % 0.00 Tick N/A
Bid 94.81 Bid Size 100.00 Ask 95.00 Ask Size 100.00
Open N/A High N/A Low N/A Prev Close 93.83
Last Trade Volume 195 52 Wk Hi 106.74 52 Wk Low 75.81
Market Cap 16.7 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 178,062,106.00 EPS (TTM) -0.71 PE Ratio N/A Exchange NGS
  Last 3 Mo Last 12 Mo
Number of Insider Trades 95 203
Number of Buys 38 88
Number of Sells 57 115
Net Activity -209011 304528
Last 10 Buys Shares
Robert A. Baffi 1,000
Mark Wood 1,000
Brian Mueller 1,000
Jean-Jacques Bienaime 1,000
Steve Aselage 1,000
Jeffrey H. Cooper 1,000
Jean-Jacques Bienaime 1,000
Richard A. Meier 1,000
Richard A. Meier 1,000
Last 10 Sell Shares
Jeff Ajer 1,000
Jean-Jacques Bienaime 1,000
Jean-Jacques Bienaime 1,000
Jean-Jacques Bienaime 1,000
Jean-Jacques Bienaime 1,000
Jean-Jacques Bienaime 1,000
Jean-Jacques Bienaime 1,000
Brian Mueller 1,000
Jeff Ajer 1,000
Jean-Jacques Bienaime 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 150 150 150 150
Low Target Price Estimate 89 89 89 89
Mean Target Price Estimate 114.53 114.21 113.56 114.53
Standard Deviation 16.44 16.12 17.37 16.44
Date of Most Recent Estimate 05/31/18 05/25/18 05/23/18 06/12/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 16 15 16 16
Moderate Buy 2 2 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.27 1.29 1.27 1.27